Solent Airport transformation featured in new ITV News documentary
The ITV News film explores the evolution of the site at Daedalus, tracing its journey from its military origins as HMS Daedalus.
It also highlights the site's current role as a centre for aviation, aerospace engineering, and advanced manufacturing.
Councillor Simon Martin, leader of Fareham Borough Council, said: "I am delighted that Solent Airport and the wider Daedalus site have been highlighted in this series featured by ITV.
"Daedalus is not only loved by local people for its history and heritage, but it has also become a fantastic success story for the borough.
"The council's role is to improve the local area as well as provide jobs and this site does both in abundance."
READ MORE: No plans to sell off allotments in Southampton, senior councillor confirms
Since its purchase by the council in 2015, the site has seen significant investment and now supports hundreds of jobs and up to 30,000 flight movements annually.
The documentary 'Inside Solent Airport: The evolution of Daedalus' is available to view on ITVX.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Why Astronics (ATRO) Raised Its Revenue Guidance and What It Means for Aerospace Growth
Astronics Corporation recently reported its second quarter 2025 earnings, noting sales of US$204.68 million and net income of US$1.31 million, with the company raising its full-year revenue guidance to a range of US$840 million to US$860 million. This guidance increase reflects strong performance in the Aerospace segment and management confidence amid restructuring and ongoing tariff challenges. Given Astronics' upgraded revenue guidance, we will explore how this development may influence its investment narrative and outlook for aerospace-driven growth. AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. Astronics Investment Narrative Recap To be a shareholder in Astronics, you need to believe in the ongoing recovery and future growth of global commercial aerospace, the company's ability to capitalize on increased aircraft production rates, and its progress in streamlining operations to drive margin improvement. The latest results, including raised revenue guidance and continued strength in Aerospace, bolster management's near-term confidence, but do not materially diminish the most pressing risk: unpredictable tariff costs that threaten profit margins and execution in the Test segment. Among recent announcements, the upward revision of full-year revenue guidance directly aligns with increased aircraft demand and robust sales in the Aerospace segment, reinforcing the key catalyst of production rate increases at major OEMs. While this supports optimism about revenue growth, execution risk in the Test segment and cost management amid persistent tariff headwinds are still critical factors for shareholders to monitor. But just as revenue potential rises, investors should be aware of ongoing exposure to tariff unpredictability and potential cost pressures in... Read the full narrative on Astronics (it's free!) Astronics' outlook anticipates $956.5 million in revenue and $86.1 million in earnings by 2028. This projection relies on a 5.1% annual revenue growth rate and an increase in earnings of $89.8 million from the current -$3.7 million. Uncover how Astronics' forecasts yield a $38.58 fair value, a 15% upside to its current price. Exploring Other Perspectives Three Simply Wall St Community fair value estimates for Astronics range from US$15 to US$207.24, showing a wide range of views. With tariffs posing a real cost concern, it's worth exploring how each perspective frames the company's risk and reward. Explore 3 other fair value estimates on Astronics - why the stock might be worth over 6x more than the current price! Build Your Own Astronics Narrative Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd. A great starting point for your Astronics research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision. Our free Astronics research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Astronics' overall financial health at a glance. No Opportunity In Astronics? Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters: Outshine the giants: these 19 early-stage AI stocks could fund your retirement. These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ATRO. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
24 minutes ago
- Bloomberg
A London Apartment Tower With Echoes of Victorian Rail and Ancient Rome
Across large parts of London, architects and developers face a common conundrum. On one hand, they need to create contemporary, state-of-the art buildings that maximize a site's potential. On the other hand, they also need to be acutely sensitive to historic cityscapes, or risk being either denied planning permission or facing accusations of ruining the city.
Yahoo
40 minutes ago
- Yahoo
Is this the FTSE 100's greatest recovery stock right now?
Investors remain unconvinced by Persimmon's (LSE:PSN) credentials as a potential FTSE 100 recovery stock. They are unmoved even after a largely impressive trading update on Wednesday (13 August). In it, the housebuilder said that 'our average sales price, sales, completions, planning approvals, active sites and forward order book' all rose in the six months to June. In fact, Persimmon's share price dropped again following the release. It's now down 6.3% in the year to date. Are investors missing a chance to snap up what could be an exceptional turnaround stock? The recovery continues The housebuilding industry's post-2023 rebound has been bumpy at times. But supported by steady interest rate cuts, its upward momentum continues. Persimmon's latest trading statement shows it remains firmly on the comeback trail. It showed housing revenues up 12% in the six months to June. Total completions rose 4%, and average selling prices improved 8%. Better sales volumes, married with self-help measures, pushed the company's underlying operating margin 10 basis points higher. Underlying operating profit increased 13%. The builder's robust performance means it remains confident of a sustained recovery over the medium term. Completions are tipped to increase in 2025, to 11,000-11,500 from 10,664 last year, and again to 12,000 in 2026. A full-year underlying operating margin of 14.2%-14.5% is also expected. That's up from 14.1% in 2024. So what's occurring then? Put simply, investors are considering the fragility of the housing market recovery. Given signs of stagnating economic growth and a deteriorating jobs market, I can hardly blame them. Persimmon itself has warned of the threat of 'geopolitical events and challenging market conditions, including uncertainty in advance of the Budget' in autumn. Yet, tough economic conditions, rising living costs, and increased Stamp Duty haven't derailed the industry's recovery, so far. Latest Halifax data showed average home prices up 0.4% in July, the fastest rate of growth so far in 2025. Persimmon also continues to ride high — net private sales rates were 0.61 in the five weeks from 30 June, up from 0.55 in the same 2024 period. With further interest rate cuts tipped, and fierce competition among Britain's lenders also helping buyer affordability, I'm confident the sector rebound can continue. I'm not alone — Halifax's head of mortgages Amanda Bryden expects 'house prices to follow a steady path of modest gains through the rest of the year'. A 45% return? Given this supportive backdrop, City analysts think Persimmon's share price can rebound sharply over the next 12 months. The average target among the 16 analysts with ratings on the housebuilder is £15.33 per share. That's up a stunning 38.4% from current levels. With the builder packing a huge 5.6% forward dividend yield, too, investors today might enjoy a total return just a shade below 45% over the next year. Near-term challenges threaten Persimmon's potential to be the FTSE 100's best recovery stock. But given its strong operational progress and the likelihood of further interest rate reductions, I think it's still a top UK share to consider. The post Is this the FTSE 100's greatest recovery stock right now? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Royston Wild has positions in Persimmon Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data